Wolfgang H Dillmann Selected Research

Proteins (Proteins, Gene)

1/2020	Overexpression of p53 due to excess protein O-GlcNAcylation is associated with coronary microvascular disease in type 2 diabetes.
12/2016	Cardiac-Directed Expression of Adenylyl Cyclase Catalytic Domain Reverses Cardiac Dysfunction Caused by Sustained Beta-Adrenergic Receptor Stimulation.
10/2012	Excess protein O-GlcNAcylation and the progression of diabetic cardiomyopathy.
6/2011	Regulation of mitochondrial morphology and function by O-GlcNAcylation in neonatal cardiac myocytes.
11/2008	Conditional increase in SERCA2a protein is able to reverse contractile dysfunction and abnormal calcium flux in established diabetic cardiomyopathy.
7/2008	Downregulation of connexin40 is associated with coronary endothelial cell dysfunction in streptozotocin-induced diabetic mice.
1/2008	Mitochondria protection from hypoxia/reoxygenation injury with mitochondria heat shock protein 70 overexpression.
10/2005	Effects of hyperthyroidism on delayed rectifier K+ currents in left and right murine atria.
1/2004	In vivo adenoviral transfer of sorcin reverses cardiac contractile abnormalities of diabetic cardiomyopathy.
11/2003	Diabetes and the accompanying hyperglycemia impairs cardiomyocyte calcium cycling through increased nuclear O-GlcNAcylation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wolfgang H Dillmann Research Topics

Disease

9	Hyperglycemia 10/2020 - 11/2003
8	Ischemia 10/2013 - 07/2002
7	Diabetic Cardiomyopathies 10/2020 - 04/2002
7	Heart Failure 09/2013 - 01/2004
6	Cardiomyopathies (Cardiomyopathy) 01/2022 - 04/2002
6	Cardiomegaly (Heart Hypertrophy) 10/2012 - 01/2002
4	Mitochondrial Diseases (Mitochondrial Disease) 10/2020 - 07/2002
4	Infections 01/2008 - 10/2003
3	Diabetes Mellitus 01/2021 - 01/2009
3	Type 2 Diabetes Mellitus (MODY) 01/2020 - 12/2004
3	Body Weight (Weight, Body) 10/2012 - 01/2002
3	Hypertrophy 12/2010 - 01/2002
2	Obesity 01/2022 - 10/2012
2	Inflammation (Inflammations) 01/2022 - 01/2012
2	Hypertension (High Blood Pressure) 01/2022 - 12/2007
2	Fibrosis (Cirrhosis) 01/2022 - 10/2012
2	Heart Diseases (Heart Disease) 01/2021 - 04/2020
2	Microvascular Rarefaction 01/2020 - 04/2009
2	Reperfusion Injury 10/2013 - 12/2004
2	Hypoxia (Hypoxemia) 01/2008 - 07/2002
2	Hyperthyroidism 10/2005 - 08/2005
1	Pheochromocytoma 01/2022
1	Bites and Stings (Sting) 01/2022
1	Cardiac Arrhythmias (Arrythmia) 06/2016
1	Polymorphic catecholergic ventricular tachycardia 06/2016
1	Myocardial Infarction 08/2014
1	Diastolic Heart Failure 10/2013
1	Pulmonary Valve Insufficiency (Insufficiency, Pulmonary Valve) 10/2013
1	Anthrax 10/2013
1	Infarction (Infarctions) 10/2013
1	Hyperinsulinism (Hyperinsulinemia) 10/2012
1	Left Ventricular Dysfunction 10/2012
1	Edema (Dropsy) 01/2012
1	Lung Injury 01/2012
1	Pancreatitis 01/2012
1	Necrosis 01/2012
1	Atrophy 06/2011
1	Colitis 02/2010
1	Ototoxicity 07/2009
1	Hearing Loss (Hearing Impairment) 07/2009
1	Chronic Disease (Chronic Diseases) 12/2007
1	Myotonic Dystrophy (Dystrophia Myotonica) 11/2007
1	Parathyroid Neoplasms (Parathyroid Neoplasm) 01/2006
1	Hypocalcemia 01/2006

Drug/Important Bio-Agent (IBA)

13	CalciumIBA 01/2021 - 04/2002
10	Proteins (Proteins, Gene)FDA Link 01/2020 - 11/2003
5	Glucose (Dextrose)FDA LinkGeneric 10/2020 - 11/2003
5	Adenosine Triphosphatases (ATPase)IBA 06/2007 - 04/2003
3	CatecholaminesIBA 01/2022 - 06/2016
3	Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA 08/2014 - 06/2007
3	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 01/2008 - 06/2006
2	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 04/2020 - 01/2004
2	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 10/2013 - 01/2002
2	phospholambanIBA 10/2013 - 09/2005
2	Thyroid HormonesIBA 12/2010 - 08/2005
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 06/2006 - 07/2002
1	Complement C3 (C3 Complement)IBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Bacterial DNAIBA 01/2022
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2022
1	InterferonsIBA 01/2022
1	Angiotensin IIIBA 01/2022
1	Cyclic GMP-Dependent Protein Kinases (Protein Kinase G)IBA 01/2022
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2022
1	Opioid Receptors (Opioid Receptor)IBA 01/2021
1	Mitochondrial DNA (mtDNA)IBA 12/2016
1	mitochondrial calcium uniporterIBA 12/2016
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2016
1	Adrenergic Agents (Adrenergic Drugs)IBA 06/2016
1	IntegrinsIBA 10/2013
1	Peptides (Polypeptides)IBA 09/2013
1	Cytochromes c (Cytochrome c)IBA 02/2013
1	CaspasesIBA 02/2013
1	Blood Glucose (Blood Sugar)IBA 10/2012
1	Sp1 Transcription FactorIBA 10/2012
1	Streptozocin (Streptozotocin)FDA Link 10/2012
1	Arginine (L-Arginine)FDA Link 01/2012
1	Lipase (Acid Lipase)FDA Link 01/2012
1	CeruletideIBA 01/2012
1	UrocortinsIBA 01/2011
1	Phosphotransferases (Kinase)IBA 12/2010
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 12/2010
1	Histone Deacetylase InhibitorsIBA 02/2010
1	Kanamycin FDA Link 07/2009
1	AminoglycosidesIBA 07/2009
1	Thyroid Hormone Receptors beta (TR beta)IBA 04/2009
1	Endothelin-1 (Endothelin 1)IBA 03/2009
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2009
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2009
1	AcetylglucosamineIBA 01/2009
1	mitochondrial transcription factor AIBA 12/2008
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 08/2008
1	Co-Repressor ProteinsIBA 08/2008
1	Pharmaceutical PreparationsIBA 12/2007
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2007
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 11/2007
1	1,25-dihydroxyvitamin DIBA 01/2006

Therapy/Procedure

1	Therapeutics 04/2020
1	Thyroidectomy 01/2006
1	Parathyroidectomy 01/2006